[go: up one dir, main page]

ATE477331T1 - Verfahren zum nachweis einer hiv-infektion - Google Patents

Verfahren zum nachweis einer hiv-infektion

Info

Publication number
ATE477331T1
ATE477331T1 AT07756200T AT07756200T ATE477331T1 AT E477331 T1 ATE477331 T1 AT E477331T1 AT 07756200 T AT07756200 T AT 07756200T AT 07756200 T AT07756200 T AT 07756200T AT E477331 T1 ATE477331 T1 AT E477331T1
Authority
AT
Austria
Prior art keywords
hiv infection
detecting hiv
infection
hiv
afd
Prior art date
Application number
AT07756200T
Other languages
English (en)
Inventor
Yuntao Wu
Dongyang Yu
Jeremy Kelly
Rebecca Yoder
Original Assignee
George Mason Intellectual Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Mason Intellectual Prop filed Critical George Mason Intellectual Prop
Application granted granted Critical
Publication of ATE477331T1 publication Critical patent/ATE477331T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
AT07756200T 2006-05-05 2007-05-04 Verfahren zum nachweis einer hiv-infektion ATE477331T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79774506P 2006-05-05 2006-05-05
US89415007P 2007-03-09 2007-03-09
PCT/US2007/010750 WO2007130523A2 (en) 2006-05-05 2007-05-04 Compositions and methods for detecting and treating hiv infection

Publications (1)

Publication Number Publication Date
ATE477331T1 true ATE477331T1 (de) 2010-08-15

Family

ID=38624429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07756200T ATE477331T1 (de) 2006-05-05 2007-05-04 Verfahren zum nachweis einer hiv-infektion

Country Status (6)

Country Link
US (2) US7662547B2 (de)
EP (2) EP2236620A3 (de)
AT (1) ATE477331T1 (de)
CA (1) CA2651317A1 (de)
DE (1) DE602007008398D1 (de)
WO (1) WO2007130523A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2307367B1 (de) 2008-07-08 2014-09-24 Board of Regents, The University of Texas System Neue hemmer der proliferation und aktivierung signalübertragender und transkriptionsaktivierender (stat) proteine
US8450337B2 (en) 2008-09-30 2013-05-28 Moleculin, Llc Methods of treating skin disorders with caffeic acid analogs
EP3037421A3 (de) 2008-11-25 2016-11-30 University Of Rochester Mlk-hemmer und verfahren zur verwendung
US20130109687A1 (en) * 2010-04-30 2013-05-02 Gary J. Nabel Methods of treating hiv infection: inhibition of dna dependent protein kinase
WO2013025700A1 (en) * 2011-08-15 2013-02-21 Albert Einstein College Of Medicine Of Yeshiva University Phosphocofilin: cofilin co-localization intensity as a predictor of metastic recurrence
EP2925319B1 (de) 2012-11-30 2019-01-09 University Of Rochester Mixed-lineage-kinaseinhibitoren für hiv/aids-therapien
TWI629720B (zh) * 2015-09-30 2018-07-11 東京威力科創股份有限公司 用於濕蝕刻製程之溫度的動態控制之方法及設備
CN106074567A (zh) * 2016-07-05 2016-11-09 湖北医药学院 葫芦素b在制备蛋白磷酸酶2a癌性抑制因子抑制剂中的应用
US20190343801A1 (en) * 2017-01-17 2019-11-14 Bar Ilan University Compositions and methods for controlling natural killer cell activation and function
CN112055715A (zh) * 2018-01-23 2020-12-08 富荣吉有限责任公司 使用cofilin磷酸化定量检测cd4 t细胞损伤和预测抗逆转录病毒治疗后cd4 t细胞恢复
CN110194793B (zh) * 2018-02-26 2020-12-01 中国科学院武汉病毒研究所 一种抑制肌动蛋白重组的多肽及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932221A (en) * 1997-10-30 1999-08-03 Day; Charles E. Genistin-enriched fraction from soy meal
US7052676B2 (en) * 2000-09-26 2006-05-30 The Regents Of The University Of Michigan Methods for inhibition of HIV replication using a small molecule inhibitor
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
ES2687657T3 (es) * 2003-05-27 2018-10-26 Dsm Ip Assets B.V. Nuevas composiciones nutracéuticas y uso de las mismas
EP1542016A1 (de) 2003-12-11 2005-06-15 Institut Gustave Roussy PUMA, phosphoryliertes p53 und p38 MAPK als Marker für HIV-induzierte Apoptose in zirkulierenden T-Zellen eines infizierten Patienten
WO2005103654A2 (fr) * 2004-04-09 2005-11-03 Bioalliance Pharma Methode d’identification de composes actifs sur la replication du virus hiv.

Also Published As

Publication number Publication date
EP2236620A3 (de) 2011-05-25
US20100292181A1 (en) 2010-11-18
CA2651317A1 (en) 2007-11-15
WO2007130523A3 (en) 2008-06-19
WO2007130523A2 (en) 2007-11-15
US20080064026A1 (en) 2008-03-13
DE602007008398D1 (de) 2010-09-23
EP2021496B1 (de) 2010-08-11
US7662547B2 (en) 2010-02-16
EP2236620A2 (de) 2010-10-06
EP2021496A2 (de) 2009-02-11

Similar Documents

Publication Publication Date Title
ATE477331T1 (de) Verfahren zum nachweis einer hiv-infektion
EP3815004A4 (de) Verfahren zur erkennung einer umgebungsanomalie und einleitung einer verbesserten automatischen reaktion
ATE531820T1 (de) Gesundheitszustandstest
EP3796297A4 (de) Anzeigetafel und risserkennungsverfahren dafür sowie anzeigevorrichtung
DE602007006478D1 (de) Erkennung der verbindung einer dna-rekombination
ATE499602T1 (de) Signalprozessierungsschaltkreis mit ionensensitivem feldeffekttransistor sowie verfahren zur überwachung einer eigenschaft einer flüssigkeit
BRPI0923772A2 (pt) artigos absorventes com indicadores visuais de saturação e áreas de marcação primárias e secundárias.
ATE523053T1 (de) Verfahren zur erhöhung der positionsverfügbarkeit
ATE537098T1 (de) System und verfahren zur erfassung der position einer aufzugskabine
JOP20190280A1 (ar) مثبطات fgfr2 لعلاج سرطان الأوعية الصفراوية
ATE498134T1 (de) Nachweis von staphylococcus
DK2310043T3 (da) Von Willebrand faktor eller faktor VII samt von Willebrand faktor til behandling af koagulationsdefekt induceret af trombocythæmmere
DE602006009927D1 (de) Verfahren und System zur Bereitstellung eines Tonsignals mit erweiterter Bandbreite
EP3812729A4 (de) Vorrichtung zur detektion von schlupf
EP4058780A4 (de) System und verfahren zur chemischen detektion und amplifikation
EP1883252A4 (de) Vorrichtung zur detektion von anomalien
DE502005003785D1 (de) Auigkeit von windkanalmessungen zur korrektur des einflusses einer aufhaengungsvorrichtung
EP3473715A4 (de) Katalaseinhibitor und verfahren zur messung von analyten unter verwendung des katalaseinhibitors
EP4288884A4 (de) System zur erkennung von schadprogrammen
DE602007007577D1 (de) Vorrichtung zur dämpfung von kettengeräuschen
EP3928078A4 (de) Vorrichtung, verfahren und system zur detektion der anwesenheit einer flüssigkeit
ATE551605T1 (de) Verfahren und vorrichtungen zur erkennung von biofilmen
DE602005027919D1 (de) Vorrichtung zur Verhinderung einer lateralen Verschiebung für Stabilisatoren
DE602005013633D1 (de) Vorrichtung zur Detektion von atmosphärischer Turbulenz
EP4097460C0 (de) System zur detektion von analyten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties